Publications by authors named "Joseph Jude Aarthi"

2 Publications

  • Page 1 of 1

Oncomirs: the potential role of non-coding microRNAs in understanding cancer.

Bioinformation 2008 May 20;2(8):330-4. Epub 2008 May 20.

Department of Physiology, MD9, 2 Medical Drive, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

MicroRNAs (miRNAs) are members of a family of non-coding RNAs of 8-24 nucleotide RNA molecules that regulate target mRNAs. The first miRNAs, lin-4 and let-7, were first discovered in the year 1993 by Ambros, Ruvkun, and co-workers while studying development in Caenorhabditis elegans. miRNAs can play vital functions form C. elegans to higher vertebrates by typical Watson-Crick base pairing to specific mRNAs to regulate the expression of a specific gene. It has been well established that multicellular eukaryotes utilize miRNAs to regulate many biological processes such as embryonic development, proliferation, differentiation, and cell death. Recent studies have shown that miRNAs may provide new insight in cancer research. A recent study demonstrated that more than 50% of miRNA genes are located in fragile sites and cancer-associated genomic regions, suggesting that miRNAs may play a more important role in the pathogenesis of human cancers. Exploiting the emerging knowledge of miRNAs for the development of new human therapeutic applications will be important. Recent studies suggest that miRNA expression profiling can be correlated with disease pathogenesis and prognosis, and may ultimately be useful in the management of human cancer. In this review, we focus on how miRNAs regulate tumorigenesis by acting as oncogenes and anti-oncogenes in higher eukaryotes.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.6026/97320630002330DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2478731PMC
May 2008

RNAi and RNAa--the yin and yang of RNAome.

Bioinformation 2008 Jan 11;2(6):235-7. Epub 2008 Jan 11.

Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

RNA interference (RNAi) is a powerful technology with huge applications for functional genomics, target identification in drug discovery and elucidation of molecular signaling pathways. Current RNAi studies have demonstrated the clinical potential of small interfering RNAs (siRNAs) in metabolic diseases, cancer, AIDS, malaria, neurodegenerative disorders, dental diseases and other illnesses. Interestingly, recent studies have shown that the small RNA molecules, either indigenously produced as microRNAs (miRNAs) or exogenously administered synthetic dsRNAs could effectively activate a particular gene in a sequence specific manner instead of silencing it. This novel, but still uncharacterized, phenomenon has been termed as RNA activation (RNAa). The paradoxical concept of Yin and Yang, which describe two primal opposing but complementary principles, can potentially be applied to elucidate the complex phenomenon of RNAa/RNAi in the RNAome. This warrants a proper understanding of the RNAi/RNAa molecular pathways in living organisms before any of the small dsRNAs can potentially be exploited for therapeutics in human beings.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.6026/97320630002235DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2258431PMC
January 2008
-->